Three tests that can be used to profile the genetic makeup of breast cancer tumours and guide decisions on whether people will respond to chemotherapy have been approved for NHS use. The National ...
The diagnostics advisory committee considered evidence on tumour profiling tests to guide adjuvant chemotherapy decisions in lymph node (LN)‑positive early breast cancer from several sources, ...
BOSTON & EL MONTE, Calif.--(BUSINESS WIRE)--Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced plans to launch two new germline tests, ...
PALO ALTO, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Flatiron Health, a leading healthtech company dedicated to ...
UAB Pathology and the Division of Genomic Diagnostics and Bioinformatics are pleased to announce a new next-generation sequencing (NGS) comprehensive genomic profiling (CGP) Solid500 test which ...
GUARDANT HEALTH LAUNCHES GUARDANT360 TISSUE, FIRST TISSUE MOLECULAR PROFILING TEST WITH COMPREHENSIVE MULTIOMIC ANALYSIS TO PROVIDE A MORE COMPLETE VIEW OF CANCER Powered by Guardant Infinity smart ...
The company expands precision oncology portfolio with new Paletrra spatial proteomics platform "The debut of the PanTracer Family and Paletrra represents a significant milestone for NeoGenomics and a ...
A state-run outfit is conducting “neuroprofiling” tests on 10,000 children and teens to identify leaders and “anti-leaders” in a bid to boost patriotism and funnel young people into roles the results ...
As 2026 approaches, doctors urge prioritising preventive health tests to catch illnesses early. Key screenings like CBC, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback